Dithiol gliotoxin is a near-terminal biosynthetic intermediate from the gliotoxin biosynthetic pathway in the human pathogen Aspergillus fumigatus. Chemically reduced gliotoxin, dithiol gliotoxin (DTG), is revealed as a biological zinc chelator, and conversely, zinc can relieve the hitherto cryptic fungal autotoxicity of DTG. There is a systems-wide impact of zinc chelation by DTG on the fungal proteome, and we suggest it is DTG, as opposed to gliotoxin, which chelates zinc from metalloproteins. Since gliotoxin can be sequestered by both fungi and bacteria, our findings infer a new avenue to interfere with, and exploit, cellular zinc homeostasis in microorganisms.
-dependent enzymes, while proteins were protected from aggregation by pre-incubating DTG with Zn 2+ . We conclude that DTG can act in vivo as a Zn 2+ chelator, which can significantly impede A. fumigatus growth in the absence of GliT and GtmA.
Introduction
Gliotoxin and holomycin are microbial natural products, which are produced by fungal and bacterial spp., respectively (Fig. 1 ). [1] [2] [3] Both are low molecular mass metabolites, and each contains a disulphide bridge formed by the action of oxidoreductases, namely GliT and HlmI, on the respective dithiol precursor (Fig. 1 ). [4] [5] [6] Disulphide bridge formation is essential for microbial self-protection against these reactive dithiol intermediates, and is a pre-requisite for the Major Facilitator Superfamily transporter GliA-mediated secretion of gliotoxin by Aspergillus fumigatus.
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Both metabolites are also present as bis-thiomethylated forms, and gliotoxin bis-thiomethyltransferase GtmA converts dithiol gliotoxin (DTG) to bis-dethiobis(methylthio)gliotoxin (BmGT) in A. fumigatus, whereas the origin of the cognate activity against dithiol holomycin in Streptomyces clavuligeris is unknown (Fig. 1 ).
gliotoxin is chemically reduced to the dithiol form by intracellular glutathione (GSH). 11 Carberry et al. revealed significantly elevated intracellular GSH in gliotoxin-sensitive A. fumigatus DgliT and that Saccharomyces cerevisiae Dgsh1, deficient in intracellular GSH, was resistant to exogenous gliotoxin. 12 The epipolythiodioxopiperazine (ETP) gliotoxin autoinduces its own biosynthesis by activating gli biosynthetic gene cluster expression, and BmGT formation has been shown to result in gli cluster attenuation in A. fumigatus, which results in the repression of gliotoxin biosynthesis. 9, 13, 14 Methylation of dithiol holomycin has been proposed as a back-up plan for self-protection, and Dolan et al. revealed that A. fumigatus DgliT::DgtmA is significantly more sensitive to exogenous gliotoxin than a gliT-deficient mutant. 15 This suggests that the combined absence of both self-protection and negative regulation of DTG biosynthesis (or its intracellular presence) results in potent growth retardation -the precise cause of which is unknown. 10, 15 Gliotoxin, other ETPs and dithiolopyrrolones have been shown to inhibit the activity of many enzymes, and functionality of specific proteins. [16] [17] [18] [19] [20] [21] Several studies have demonstrated that the disulphide moiety of gliotoxin is responsible for most of the associated bioactivity of this molecule, whereas the S-methylated BmGT molecule is relatively inactive. 17, 22 In general, reactivity of gliotoxin towards protein thiols, damage from redox cycling, and Zn 2+ ejection have been proposed as the respective mechanisms whereby protein functionality is altered. Interestingly, addition of the reducing agent, L-dithiothreitol (DTT), significantly augmented the inhibitory activity of gliotoxin towards farnesyltransferase, and either DTT or GSH augmented gliotoxin-mediated inhibition of equine alcohol dehydrogenase. 16, 17 Notably, neither of the aforementioned studies posited DTG-mediated Zn 2+ chelation from either Zn
2+
-dependent enzyme as the inhibitory mechanism.
In combination, these observations led us to hypothesise that, acting as a potent Zn 2+ chelator, DTG (and not gliotoxin), 
Extraction and measurement of extracellular and intracellular gliotoxin
A. fumigatus wild-type and DgliT::DgtmA were grown in Sabourauddextrose media for 21 h and gliotoxin was subsequently added for 3 h at 15 mM with and without Zn 2+ (n = 3 biological replicates for all specimens). Zn 2+ was added at 1 mM final concentration.
Supernatant samples were taken after 15, 30, 60, 120 and 180 min and were extracted using chloroform (1 : 1), as described. 31 The organic extracts were subsequently dried down and resuspended in methanol and analysed for gliotoxin content using RP-HPLC with UV detection (Shimadzu), using polar C18 RP-HPLC column (Phenomenex polar C18 Luna Omega column (150 mm Â 4.6 mm, 5 mm)) at a flow rate of 1 ml min
À1
. A mobile phase of acetonitrile and water with 0.1% (v/v) TFA was used under gradient conditions. A. fumigatus wild-type was also grown in Czapek-Dox media for 72 h (gliotoxin-producing conditions) in the presence of either low (0.027 mM) or high (0.5 mM) Zn 2+ (n = 3 biological replicates for all specimens). Controls were included, with no Zn 2+ added. Aliquots were taken every 24 h and organic extractions and RP-HPLC analyses were performed as outlined above. For intracellular gliotoxin recovery, mycelia collected after 3 h incubation were harvested and snap frozen in liquid N 2 . Intracellular gliotoxin was extracted as described previously for SAM, using a modified protocol. 8 Briefly, mycelia were ground using liquid N 2 with a mortar and pestle. 100 mg mycelia were incubated with 0.1 N HCl (250 ml) on ice for 1 h with intermittent vortexing. Protein was removed by addition of 100% TCA to achieve a final concentration of 15% (v/v) TCA. After centrifugation at 16 000 Â g, supernatants were collected and then analysed by RP-HPLC.
Proteomic analysis of gliotoxin affects, with and without Zn 2+ , on A. fumigatus DgliT A. fumigatus DgliT was cultured (n = 3/condition) for 21 h in Sabouraud-dextrose media (SDM) followed by addition of gliotoxin (15 mM) or methanol (control) with and without ZnSO 4 (1 mM) addition for 3 h. Mycelia were then harvested and snap frozen in liquid N 2 . Mycelia were lysed using buffer (100 mM Tris-HCl, 50 mM NaCl, 20 mM EDTA, 10% v/v glycerol. 1 mM PMSF, 1 mg ml À1 pepstatin A, pH 7.5) with grinding and sonication, and clarified using centrifugation. 8 The protein lysates were then subjected to precipitation using TCA/acetone and resuspended in 100 mM Tris-HCl, 6 M urea, 2 M thiourea, pH 8.0. Samples were then reduced by DTT and followed by alkylation using IAA. This was followed by addition of sequencing grade trypsin combined with Protease Max surfactant for overnight digestion. Following sample clean-up using Millipore C18 ZipTips, all peptide mixtures were analysed via a Thermo-Fisher Q-Exactive mass spectrometer coupled to a Dionex RSLCnano.
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LC gradients ran from 4% to 35% ACN over 2 h, and data were collected using a Top15 method for MS/MS scans. Comparative proteome abundance and data analysis was performed using MaxQuant software (v. 1.5.3.30), with PERSEUS used to organize data (v. 1.5.4.0). 33, 34 Proteins with significant changes in abundance (p o 0.05; fold change Z2) signified quantitative changes between the sample treatments. Qualitative differences were also noted, where proteins were not detected in one group and were present in at least 2 replicates from the comparator group. Functional analysis was carried out using FungiFun2 (https:// elbe.hki-jena.de/fungifun/fungifun.php).
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In vitro DTG induced-protein aggregation assays Protein extracts were prepared from A. fumigatus mycelia from three biological replicates, previously cultured in SDM at 37 1C, for 24 h at 200 rpm. Mycelia were harvested by filtering through Miracloth, snap-frozen and ground in liquid N 2 using a pestle and mortar. Lysis buffer (0.1 M Tris-HCl, 50 mM NaCl, 1 mM PMSF pH 7.5; 400 ml) was added to ground mycelia (200 mg) and lysed by sonication. Lysates were clarified by centrifugation at 12 000g, 4 1C for 10 min and this was repeated twice to remove insoluble material. Lysates were diluted to 1 mg ml À1 and subjected to the following treatments in triplicate: (a) control: methanol and TCEP were added as a solvent control; (b) DTG: TCEP-reduced gliotoxin was added to the protein extracts to a final concentration of 150 mM and (c) DTG/Zn 2+ :TCEP-reduced gliotoxin was pre-mixed with ZnSO 4 Á7H 2 O at a 1 : 3 molar ratio.
The mixture was added to the protein extracts in triplicate to achieve a final concentration of 150 mM DTG and 450 mM Zn 2+ .
All samples were incubated at 50 1C for 30 min prior to addition of solubilisation buffer and analysis by SDS-PAGE. Protein aggregates were observed as a band of Coomassie-stained protein at the interface between the stacking and resolving gels. These bands were excised and subjected to in-gel digestion according to Shevchenko et al. 36 Peptide mixtures were de-salted using C 18 Zip-tips and analysed using Label-free quantitative proteomics (Thermo Q-Exactive LC-MS). Data analysis was performed using MaxQuant with Perseus for data organisation and statistical analysis. Relevantly, gliotoxin had no effect on Zn(PAR) 2 interaction which confirmed the specific role of the dithiol moiety of reduced gliotoxin in chelation (Fig. S2 , ESI †). To investigate the effect of Zn 2+ on the enzymatic S-methylation of DTG, a
GtmA activity assay was performed. GtmA bis-thiomethylates DTG to form BmGT using SAM as the methyl source (Fig. 1 ).
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Gliotoxin S-methylation occurs in a sequential manner, with mono-methylated species (MmGT) appearing initially, followed by formation of BmGT. 9,15,37 Zn 2+ inhibits GtmA-mediated thiomethylation of gliotoxin in vitro in a concentration-dependent manner, most likely due to an inability to recognise and bind Zn 2+
[DTG] (Fig. 2C) . Support for DTG thiol protection by Zn 2+ coordination was provided by an alkylation assay. Although IAA modifies DTG to alkylated gliotoxin, Zn 2+ also inhibits alkylation of DTG which further strengthens the concept of thiol occlusion via Zn 2+ chelation ( Fig. 2D and Fig. S3 , ESI †).
DTG inhibits AP by Zn 2+ chelation
To investigate the ability of DTG to inhibit the activity of a zincdependent metalloenzyme, AP activity assays were carried out. Gliotoxin was reduced to DTG as described above and confirmed by RP-HPLC (data not shown). DTG inhibited AP in a dosedependent manner (0-150 mM DTG) and time-dependent manner ( Fig. 3A and Fig. S4 , ESI †). Solvent controls (containing TCEP and methanol) did not show any significant AP inhibition. While 50 mM DTG significantly inhibited AP activity (p o 0.001), preincubation of DTG (50 mM) with Zn 2+ (25 mM-1 mM) alleviated DTG-associated AP inhibition (Fig. 3B) . The Zn 2+ chelator TPEN was also tested, but only produced a minor decrease in AP activity (11%) when used at the same concentration as DTG (50 mM) (Fig. 3C) . EDTA (5 mM), a metal ion chelator, inhibited AP activity by approx. 30-40% (Fig. S5 , ESI †). AP activity was not significantly inhibited by 150 mM GT, 50 mM-5 mM of the cellular reductant GSH or 50 mM-1 mM of the thiol-containing reductant DTT ( /GT compared to gliotoxin alone (Table 1 and Fig. S9, ESI †) . Notably, secondary metabolism-associated proteins were altered in abundance, or demonstrated qualitative changes in the combined condition (Zn 2+ /GT) compared to gliotoxin only (Table 2) . These included the ferricrocin synthetase SidC, which was repressed by gliotoxin, but not by the combined condition, as were four members of the fumagillin biosynthetic cluster (Table 2 and Table S1 , ESI †). Consequently, when A. fumigatus was grown in gliotoxin-producing conditions, Zn 2+ caused a significant increase in fumagillin levels even at lower levels (0.027 mM Zn
2+
; p o 0.001) (Fig. S10 , ESI †).
Low affinity zinc transporter ZrfB, which is ZafA-dependent and normally induced by zinc depletion, was undetectable in the combinatorial exposure condition, which suggests a zinclimiting environment in gliotoxin-only exposure (Table 1) . Likewise, allergen AspF2 which is expressed under zinc-limiting conditions, and shares a divergent promoter with zrfC, was absent upon co-exposure. 39 It was also observed that GliM, a component of the gliotoxin biosynthetic capacity was absent, which infers that gliotoxin biosynthesis may be attenuated in the combinatorial exposure scenario (Table 2) . Indeed, Zn 2+ presence completely abrogated gliotoxin biosynthesis in CzapekDox media (Fig. S10, ESI †) . These observations pertaining to impeded gliotoxin biosynthesis are further supported by the absence of GpgA (AFUA_1G05210), a G-protein coupled receptor subunit, previously shown to be essential for gliotoxin production in A. fumigatus. 40 It is also notable that the nonribosomal peptide synthetase NRPS8/Pes3 41 (AFUA_5G12730) was absent following co-exposure to Zn 2+ and gliotoxin, which suggests that it may contribute to adaptation to zinc-limiting conditions. Gliotoxin exposure induces elevated GtmA abundance in A. fumigatus DgliT, 9 and Manzanares-Miralles et al. reported that gliotoxin induces significantly increased abundance of the GtmA ortholog in Aspergillus niger, in which the gli cluster is absent. 37 Interestingly, while Zn 2+ exposure alone had no significant effect on the abundance of GtmA in A. fumigatus, combinatorial exposure with gliotoxin resulted in significantly elevated GtmA abundance (18.8-fold and p o 0.01) compared to that in the presence of gliotoxin only (Table 2 ). Allied to GtmA activity data (Fig. 2C) , this suggests that in vivo chelation of Zn
by DTG may prevent substrate access to GtmA, thereby resulting in a further increased abundance of the enzyme (Fig. 5A) .
Manifestation of heat-induced in vitro protein aggregation in
A. fumigatus mycelial lysates, specifically by DTG
Inhibition of Zn

2+
-dependent enzyme activities, combined with the observed in vivo interplay between the divalent metal cation (Fig. 5B) . Mass spectrometry-based analysis of the proteins retained at the interface between the stacking and resolving gel identified 551 proteins in total from the three conditions tested. Label-free proteomics revealed 94 proteins uniquely detected or significantly elevated in the aggregates following DTG pre-treatment, relative to the control ( Fig. 5C and Table S2 , ESI †). DTG addition to A. fumigatus lysates elicits an overall increase in aggregated proteins compared to the controls. Functional analysis revealed a significant number of proteins with oxidoreductase activity (n = 27, p = 0.019), metal ion binding (n = 16, p = 0.024) and zinc ion binding (n = 7, p = 0.047) showed increased aggregation in response to DTG treatment (Fig. 5D) a Uniquely detected: protein uniquely identified in at least 2 biological replicates of either gliotoxin-only treated cultures or the combination condition (Zn 2+ /GT). lysates. Finally, it is likely that some proteins detected in the aggregates may be present as a result of non-specific physical entrapment, however, these putative, non-specifically aggregated proteins are resistant to the dissolution effects of SDS solubilisation buffer and heat (95 1C/4 min).
Discussion
Herein, we provide evidence that DTG is a Zn 2+ -chelator. We also reveal Zn 2+ -metalloenzyme inhibition specifically by DTG, and not by gliotoxin or other reducing agents (DTT or GSH). This suggests Zn 2+ chelation, as well as disulphide bridge cleavage or thiol modification, as a key mode of enzyme inhibition by DTG. We propose that DTG, acting as a Zn
2+
-chelator, can significantly inhibit growth of A. fumigatus completely deficient in essential oxidation or thiomethylation activities. Unbiased LFQ proteomics reveals that Zn 2+ can significantly modify the nature and extent of protein abundance alterations caused by A. fumigatus DgliT exposure to gliotoxin. This important revelation confirms in vivo interaction between both molecular species. Moreover, additional LFQ proteomic data reveal that in vitro, DTG can cause specific protein aggregation, manifested by heat instability, possibly due to structural alteration to known Zn Zn)-2H + Cl] À , rather than the monoisotopic peak. 24 In addition, we have found that DTG efficiently chelates Zn 2+ from Zn(PAR) 2 (60 mM), in a dose-dependent manner from 60 to 300 mM DTG. Given that Kocyła et al. have proposed an effective pK d of 12.15 at pH 7.4 for Zn(PAR) 2 , it is clear that the affinity of DTG for Zn 2+ must equate to, or exceed, this value as Zn 2+ is removed from the Zn(PAR) 2 complex when equimolar amounts of DTG are added to it. 44 However, it is not ideal to compare these complexes directly due to differences in stoichiometry. Chan et al. also deployed a PARbased assay system, which involved chelation of Zn 2+ from Zn(PAR) 2 , and subsequent formation of stable complexes to reveal that Zn 2+ is chelated by dithiol holomycin ( Fig. 1 ; termed red-holomycin in Chan et al.) with high affinity. 30 Davis et al. previously revealed and characterised alkylation of DTG using 5 0 -iodoacetamidofluorescein. 45 In the present study, we observed that IAA-mediated alkylation of DTG was inhibited by Zn
, which further underpins our proposal that a Zn[DTG] complex is formed via thiolate coordination and is stable under in vitro conditions used.
DTG acts as a potent inhibitor of the Zn 2+ -dependent enzyme, AP. Previous studies have reported the inhibitory effects of gliotoxin on mammalian Zn 2+ -dependent enzymes, without attributing this activity to zinc chelation. 16, 17 Vigushin et al. studied the inhibition of Zn 2+ -dependent farnesyltransferase (FTase) and geranyltransferase (GGTase) I by gliotoxin, proposing thiol modification of these enzymes as a possible mechanism of action. Importantly, the authors noted that these assays required the reductant DTT, which aligns with our observations of the inhibition of Zn 2+ -dependent metalloenzymes (i.e., AP) by DTG rather than gliotoxin. Our data also provides an alternative explanation for previous observations which suggested that reducing agents enhanced the inhibitory activity of gliotoxin against a Zn 2+ -dependent equine ADH. 16 Although these authors posited a redox explanation, it is equally plausible that Zn 2+ chelation by DTG effected equine ADH inhibition. This accords with our observations that prior incubation of DTG with Zn 2+ prevents inactivation of AP, and also that DTGassociated AP inhibition can be rescued by subsequent addition of Zn 2+ ( Fig. 3 and Fig. S6 , ESI †).
Relevantly, it has been shown that ETPs, in particular gliotoxin, block the interaction between Hypoxia Inducible Factor-a (HIF-a) and the transcriptional coactivator p300 by a Zn 2+ ejection mechanism. 18 Moreover, these authors noted the antiproliferative effects of ETPs, and provide significant insight into their mechanism of action in animal cells. , and its subsequent unavailability as a substrate to GtmA, as opposed to direct enzyme inhibition. Interestingly, this observation is in accordance with the effect of Zn 2+ (1 and 2 mM) exposure towards A. fumigatus DgliT, whereby combinatorial gliotoxin/Zn 2+ exposure significantly augments growth inhibition. In effect, we postulate that elevated levels of Zn 2+ may augment intracellular Zn(DTG) complex formation, resulting in non-availability to GtmA, which actually significantly increases GtmA abundance (Fig. 5A) . Thus, we speculate that Zn
-mediated disruption of GtmA functionality in A. fumigatus DgliT partially creates an inability to dissipate DTG, though not as absolute as pertains in A. fumigatus DgliT::DgtmA. Indeed, A. fumigatus DgliT::DgtmA presents an ideal system to explore the functionality of Zn 2+ -dependent systems in fungi, since the organism lacks both enzymes, GliT and GtmA, which contribute to dissipation of intracellular DTG (Fig. 6) , ultimately via either gliotoxin or BmGT efflux. 15 The significant, though incomplete,
Zn
2+
-mediated reversal of A. fumigatus DgliT::DgtmA sensitivity to exogenous gliotoxin exposure implicates either chelation of free Zn 2+ or chelation of Zn 2+ from cellular metalloenzymes, by DTG as key inhibitory mechanisms (Fig. 6 ). To our knowledge, this is the first report of an in vivo interaction between gliotoxin biosynthesis, dysregulated DTG presence and growth inhibition due to potential interference with Zn 2+ -associated growth systems. Moreover, it contributes to explaining the cryptic observation of Dolan et al. that A. fumigatus DgliT::DgtmA is the most gliotoxinsensitive mutant observed to date, 15 and also why there are two distinct enzymatic activities which can prevent intracellular DTG accumulation. Overall, these data indicate the inhibitory potential of this endogenous, and potent, Zn 2+ chelator in A. fumigatus in particular, and possibly microorganisms in general. Indeed, gliotoxin significantly inhibits growth of a range of fungi, 12, 46 and previously work has also indicated its potent anti-bacterial activity. 47 It is clear that interference with intracellular DTG levels, via gliotoxin exposure to A. fumigatus DgliT impacts on the fungal proteome, which in turn can be modulated by Zn 2+ presence.
Indeed, it has been estimated that up to 6% (600/10 000) of the A. fumigatus proteome comprises Zn 2+ -binding proteins;
interestingly, this includes a prediction of 300 Zn 2+ finger transcription factors. 48 Relevantly, co-addition of gliotoxin (Fig. S10, ESI †) .
Incubation of A. fumigatus protein lysates with DTG prior to heat treatment resulted in increased protein aggregation, compared to the solvent control. Oxidoreductases, metal-binding proteins and zinc-binding proteins were significantly enriched amongst these DTG-affected proteins (p o 0.05). DTG-induced aggregation of zinc-binding proteins including two alcohol dehydrogenases, AlcC and AFUA_1G04620, and the farnesyltransferase (AFUA_ 4G10330) was observed. This is in line with observed inhibition of mammalian homologs of these proteins by gliotoxin in reducing conditions. 16, 17 AlcC was also observed to increase in abundance in vivo when A. fumigatus DgliT was treated with a combination of gliotoxin and Zn 2+ compared to gliotoxin alone (Table S1 , ESI †), possibly to compensate for loss of activity. AlcC has been identified as the primary hypoxia-responsive ADH in A. fumigatus, with a potential role in pathogenesis, 51 while farnesyltransferase has a role in signalling and also contributes to disease. 52 Further investigation could elucidate the effect of DTG on the functionality of these proteins in A. fumigatus. Pre-incubation of DTG with excess Zn 2+ abrogated this effect, most likely through formation of Zn(DTG) complexes prior to addition to protein lysates, leading to reduced levels of protein aggregation. A number of metallopeptidases (AFUA_6G09190, AFUA_4G07910, AFUA_1G14920 and MepB) were also observed to undergo increased aggregation in response to DTG, while this was prevented in the presence of Zn . These peptidases contribute to protein modification and degradation, and so alteration of these processes by DTG has the potential to disrupt protein turnover. Interestingly, gliotoxin has previously been implicated in inhibition of proteolytic activity of human and toxoplasma proteasomes. 53, 54 The cobalamin-independent methionine synthase MetH/D showed a similar response to DTG treatment, -dependent metalloenzymes, causing extreme growth inhibition. Additionally, Zn(DTG) cannot be converted to BmGT via GtmA. Either way, disruption of intracellular zinc homeostasis occurs which leads to activation of zinc uptake systems, potentially via ZafA induction of ZrfA-C expression.
absence of GliT-mediated oxidation, results in disruption of the methionine cycle, with SAM depletion caused by dysregulation of gliotoxin methylation. 8 Added to the extensive SAM consumption, DTG-associated destabilisation of methionine synthase through Zn 2+ -chelation could place an additional strain on the methionine cycle in A. fumigatus DgliT. While further studies are required to confirm if these proteins are directly affected by DTG in vivo, these results present strong targets for future investigations to elucidate the systemic effect of DTG on A. fumigatus. Of course, Zn 2+ chelation is likely not the only mechanism by which DTG exerts its effects on the cell, with previous studies illustrating its potential for thiol modification and redox reactions. 57, 58 This methodology also provides an unbiased discovery-based mechanism allowing for the identification of putative targets of DTG in other complex systems. Interestingly, Müller et al. have shown that allicin (diallyl thiosulphinate) can cause thiol stress and severe growth inhibition in bacteria. 59 Specifically, Muller et al. revealed that allicin induced protein aggregation, likely due to S-allylmercapto protein modification, in crude Escherichia coli cell lysates in a concentrationdependent manner. This is in accordance with our observations of DTG-induced protein aggregation in A. fumigatus protein lysates, although fungal protein destabilisation possibly involves Zn 2+ chelation mechanism, as opposed to protein modification. Future work will clarify the relative contribution of either mechanism. As can be seen in Fig. S8 (ESI †), gliotoxin addition to A. fumigatus results in uptake, followed by conversion to intracellular DTG and induction/augmentation of gliotoxin biosynthesis, as previously reported in Owens et al. 
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